Application 200363
- Type
- ANDA
- Sponsor
- TORRENT PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 25MG BASE | No | No |
| 002 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 50MG BASE | No | No |
| 003 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 100MG BASE | No | No |
| 004 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 200MG BASE | No | No |
| 005 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 300MG BASE | No | No |
| 006 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 400MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200363-001 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | ||
| A200363-002 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | ||
| A200363-003 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | ||
| A200363-004 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | ||
| A200363-005 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | ||
| A200363-006 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200363-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | 2012-03-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200363-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | 2012-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200363-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | 2012-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200363-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | 2012-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200363-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | 2012-03-27 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A200363-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200363-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200363-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200363-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200363-005 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200363-006 | AB | 1 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-004 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-005 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200363-006 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-004 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-005 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200363-006 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-005 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A200363-006 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-005 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A200363-006 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-005 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A200363-006 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quetiapine Fumarate | QUETIAPINE FUMARATE | Proficient Rx LP | c1f2ccba-62f3-44e7-b06f-dea61eac9e93 | 2023-04-01 | Boxed warning, Warnings, Adverse reactions | Quetiapine Fumarate QUETIAPINE FUMARATE |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Macleods Pharmaceuticals Limited | 531cbe20-dff2-4983-9788-4543079f83ff | 2023-03-16 | Boxed warning, Warnings, Adverse reactions | Quetiapine fumarate QUETIAPINE FUMARATE |
| Quetiapine Fumarate | QUETIAPINE FUMARATE | Alembic Pharmaceuticals Limited | 93ab6237-321e-4a2c-b0ca-3fc9acb31f9a | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | Quetiapine Fumarate QUETIAPINE FUMARATE |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Proficient Rx LP | 1a147d6c-8af8-4379-8a13-1864a9a79b84 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | Quetiapine fumarate QUETIAPINE FUMARATE |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Proficient Rx LP | 8048ac0a-5d4d-4d00-ab9c-7fcac27f0a60 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | Quetiapine fumarate QUETIAPINE FUMARATE |
| Quetiapine Fumarate | QUETIAPINE FUMARATE | Aphena Pharma Solutions - Tennessee, LLC | 60316ccd-c042-4ea0-9d05-3caf7cc2cab1 | 2021-10-15 | Boxed warning, Warnings, Adverse reactions | Quetiapine Fumarate QUETIAPINE FUMARATE |
| Quetiapine Fumarate | QUETIAPINE FUMARATE | Proficient Rx LP | 03517f29-f270-4350-a57a-fbe1967b0096 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | Quetiapine Fumarate QUETIAPINE FUMARATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13668-148 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-148 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-149 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-149 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-150 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-150 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-151 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-151 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-152 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-152 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-153 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
| 13668-153 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | TORRENT PHARMACEUTICALS LIMITED | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9819 | ORIG | 2012-03-30 |